|1.||Ghosh, Kanjaksha: 4 articles (01/2016 - 07/2004)|
|2.||Shoenfeld, Yehuda: 4 articles (11/2014 - 11/2002)|
|3.||Somasundaram, R: 4 articles (10/2001 - 06/2000)|
|4.||Li, W: 4 articles (10/2001 - 06/2000)|
|5.||Herlyn, D: 4 articles (10/2001 - 06/2000)|
|6.||Foon, K A: 4 articles (03/2001 - 01/2001)|
|7.||Blank, Miri: 3 articles (11/2014 - 11/2002)|
|8.||Pradhan, Vandana D: 3 articles (03/2010 - 07/2004)|
|9.||Nojima, Junzo: 3 articles (08/2009 - 05/2004)|
|10.||Herlyn, Dorothee: 3 articles (03/2003 - 04/2002)|
01/01/1984 - "Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?"
04/15/1989 - "A similar mechanism could be effective in tumor patients immunized with xenogeneic anti-idiotypic antibodies operating under the "intra(Ag) molecular help.""
06/01/2005 - "The treatment of several cancers with anti-idiotype antibodies has shown promising results in animals and clinical trials. "
10/01/1989 - "The same antibody labeled with 111-Indium (111In) was helpful in documenting the absence of anti-antibodies in six out of six patients, the presence of tumor targeting in six out of seven patients, and allowed for dose estimates in two out of six patients. "
11/01/1993 - "In this study, the contribution of idiotype-positive antitumor antibodies (anti-Id) in protective tumor immunity was investigated. "
|2.||Autoimmune Diseases (Autoimmune Disease)
11/01/2005 - "Therapeutic mAbs have shown much promise in the treatment of many disorders, including inflammatory and putative autoimmune diseases such as MS. These agents have intrinsic limitations, however, such as induction of neutralizing 'anti-antibodies', systemic inflammatory reactions and severe adverse effects, some of which remain to be explained. "
06/01/2012 - "This hypothesis is supported by the presence of anti-idiotypic antibodies in healthy individuals and in patients in remission from autoimmune diseases, and by the lack of anti-idiotypic antibodies during active disease. "
01/01/2014 - "Anti-idiotype antibodies have potential therapeutic applications in many fields, including autoimmune diseases. "
06/01/2012 - "This review provides an overview of the development and function of these anti-idiotypic antibodies, and present evidence supporting their role in the development of autoimmune diseases. "
07/01/2011 - "Sjögren's syndrome is a chronic autoimmune disease, characterized by specific autoimmune antibodies anti-Ro and anti-La, and it can involve multiple organs, such as the kidneys, lungs, muscles, and nervous system. "
11/01/2013 - "The prevalence of isolated anti-HBc among the vaccinated cohort was found to be 5.0%, out of which 80% had a hepatitis B surface antibodies (anti-HBs) titer higher than 10 IU/L, while 20% had less than 10 IU/L anti-HBs titer. "
11/01/2013 - "Hepatitis B core antibodies (anti-HBc) are detected in almost every patient with previous exposure to hepatitis B virus (HBV). "
01/01/2012 - "Although universal vaccination against hepatitis B was implemented in the United States in 1991, up to 10% of vaccine recipients fail to respond with adequate anti-hepatitis B surface antibodies (anti-HBs) levels after a primary series of vaccinations. "
04/01/2011 - "Detection of hepatitis B virus (HBV) surface antibodies (anti-HBs) is required in order to evaluate the response to hepatitis B vaccination and to optimize post-exposure monitoring. "
10/01/2010 - "Blood samples were obtained 4 weeks after vaccination or each revaccination; patients without protective hepatitis B surface antibodies (anti-HBs) were once or repeatedly revaccinated. "
01/01/1991 - "The present study describes an approach to the development and use of anti-idiotypic antibodies as a possible immunization strategy to prevent retroviral infection. "
01/01/2015 - "In this review, we update the prevalence and time course of HBV infection in lupus patients using our data and previous papers available, with a special emphasis on occult HBV infection and a decrease of HBV-related antibodies (anti-HBs and anti-HBc) under immunosuppressive therapy. "
01/01/2015 - "Furthermore, renatured scFv-His along with Mab2-5G2 were used to immunize rabbits to produce anti-anti-idiotypic antibodies (Ab3) that neutralized PRRSV infection of Marc-145 cells. "
01/01/2014 - "Monitoring of the HEV antibodies (anti-HEV) among the Russian population has revealed regions with increased seroprevalence that testifies to high probability of local HEV infection in these areas. "
01/15/2013 - "Compared to GBS patients without anti-GM1/GalNAc-GD1a antibodies, anti-GM1/GalNAc-GD1a-positive patients more frequently had a preceding respiratory infection (n=38, 66%, p<0.01) and were characterized by infrequency of cranial nerve deficits (n=9, 16%, p<0.01) and sensory disturbances (n=26, 45%, p<0.01). "
12/01/2005 - "To study serum levels of citrullinated protein/peptide antibodies (anti-CP) during up to 5 years' follow up of patients with early rheumatoid arthritis (RA), and to relate serum levels to disease course and to treatments in clinical practice. "
11/01/2015 - "To investigate the prevalence of anti-carbamylated protein antibodies (anti-CarP) in the healthy first-degree relatives (HFDRs) of patients with rheumatoid arthritis (RA). "
12/01/2014 - "Anticyclic citrullinated peptide antibodies (anti-CCP) are considered specific markers of rheumatoid arthritis (RA) and have been included in the revised classification criteria for RA diagnosis. "
01/01/2013 - "Anticyclic citrullinated peptide antibodies (anti-CCP) testing is useful in the diagnosis of rheumatoid arthritis (RA) with high specificity. "
04/01/2008 - "Anticyclic citrullinated peptide antibodies (anti-CCP) have been described almost exclusively in patients with rheumatoid arthritis. "
|2.||Intravenous Immunoglobulins (IVIG)
|5.||DNA (Deoxyribonucleic Acid)
|8.||Immunoglobulin G (IgG)
|9.||Immunoglobulin M (IgM)
|10.||Antineutrophil Cytoplasmic Antibodies (ANCA)
|3.||Renal Dialysis (Hemodialysis)